|
SRPK2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.0524999999998E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.318150E-02 |
| Normal-vs-Stage2 |
1.611220E-01 |
| Normal-vs-Stage3 |
1.118220E-01 |
| Normal-vs-Stage4 |
8.654600E-01 |
| Stage1-vs-Stage2 |
9.295200E-01 |
| Stage1-vs-Stage3 |
9.381600E-01 |
| Stage1-vs-Stage4 |
2.362000E-01 |
| Stage2-vs-Stage3 |
8.767000E-01 |
| Stage2-vs-Stage4 |
3.831600E-01 |
| Stage3-vs-Stage4 |
3.892400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.400300E-04 |
| Normal-vs-AfricanAmerican |
2.663900E-02 |
| Normal-vs-Asian |
1.707450E-01 |
| Caucasian-vs-AfricanAmerican |
9.442000E-01 |
| Caucasian-vs-Asian |
8.526400E-01 |
| AfricanAmerican-vs-Asian |
8.723000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.364300E-03 |
| Normal-vs-Female |
1.580480E-04 |
| Male-vs-Female |
4.676300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.633240E-01 |
| Normal-vs-Extreme_Weight |
2.035200E-01 |
| Normal-vs-Obese |
5.537000E-03 |
| Normal-vs-Extreme_Obese |
3.272200E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.203000E-01 |
| Normal_Weight-vs-Obese |
5.023000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.581200E-01 |
| Extreme_Weight-vs-Obese |
1.540560E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.090600E-01 |
| Obese-vs-Extreme_Obese |
9.635800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.675900E-03 |
| Normal-vs-Age(41-60Yrs) |
1.420140E-04 |
| Normal-vs-Age(61-80Yrs) |
2.008400E-02 |
| Normal-vs-Age(81-100Yrs) |
5.789400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.986000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.660450E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.851010E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.055390E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.915600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.878000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.61660000000441E-05 |
| Normal-VS-Type2 PRCC |
2.362600E-01 |
| Normal-VS-KIRP CIMP |
9.360100E-02 |
| Normal-VS-Unclassified PRCC |
1.103630E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.330300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.551600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.173200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.416800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.138100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.887200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.551200E-01 |
| Normal-vs-N1 |
4.278100E-02 |
| Normal-vs-N2 |
4.761200E-01 |
| N0-vs-N1 |
6.316300E-02 |
| N0-vs-N2 |
7.225600E-01 |
| N1-vs-N2 |
5.571000E-01 |
|
|
